The DOI matches its Crossref record; 260 of the 260 references it cites were found in a registry or an index.
The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent Insights
Abstract
IGF-I receptor (IGF-IR) signaling and functions are mediated through the activities of a complex molecular network of positive (e.g., type I IGF) and negative (e.g., the type II IGF receptor, IGF-IIR) effectors. Under normal physiological conditions, the balance between the expression and activities of these molecules is tightly controlled. Changes in this delicate balance (e.g., overexpression of one effector) may trigger a cascade of molecular events that can ultimately lead to malignancy. In recent years, evidence has been mounting that the IGF axis may be involved in human cancer progression and can be targeted for therapeutic intervention. Here we review old and more recent evidence on the role the IGF system in malignancy and highlight experimental and clinical studies that provide novel insights into the complex mechanisms that contribute to its oncogenic potential. Controversies arising from conflicting evidence on the relevance of IGF-IR and its ligands to human cancer are discussed. Our review highlights the importance of viewing the IGF axis as a complex multifactorial system and shows that changes in the expression levels of any one component of the axis, in a given malignancy, should be interpreted with caution and viewed in a wider context that takes into account the expression levels, state of activation, accessibility, and functionality of other interacting components. Because IGF targeting for anticancer therapy is rapidly becoming a clinical reality, an understanding of this complexity is timely because it is likely to have an impact on the design, mode of action, and clinical outcomes of newly developed drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Insulin-Like Growth Factors and Their Binding Proteins: Biological Actions*
JONES, J. I., & CLEMMONS, D. R. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-1-3 · Cited by 4,710
Dissemination and growth of cancer cells in metastatic sites
Chambers, A. F., Groom, A. C., & MacDonald, I. C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc865 · Cited by 3,911
Protein modules and signalling networks
Pawson, T. (1995) · Nature · doi:10.1038/373573a0 · Cited by 2,420
G 1 Events and Regulation of Cell Proliferation
Pardee, A. B. (1989) · Science · doi:10.1126/science.2683075 · Cited by 2,182
Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
Diehl, J. A., Cheng, M., Roussel, M. F., & Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.22.3499 · Cited by 2,130
Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study
Chan, J. M., Stampfer, M. J., Giovannucci, E., Gann, P. H., Ma, J., Wilkinson, P., Hennekens, C. H., & Pollak, M. (1998) · Science · doi:10.1126/science.279.5350.563 · Cited by 1,996
Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients
Bubendorf, L., Schöpfer, A., Wagner, U., Sauter, G., Moch, H., Willi, N., Gasser, T. C., & Mihatsch, M. J. (2000) · Human Pathology · doi:10.1053/hp.2000.6698 · Cited by 1,895
Ullrich, A., Gray, A., Tam, A. W., Yang-Feng, T., Tsubokawa, M., Collins, C., Henzel, W., Le Bon, T., Kathuria, S., & Chen, E. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04528.x · Cited by 1,844
GROWTH FACTOR RECEPTOR TYROSINE KINASES
Yarden, Y., & Ullrich, A. (1988) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.57.070188.002303 · Cited by 1,838
Circulating concentrations of insulin-like growth factor I and risk of breast cancer
Hankinson, S. E., Willett, W. C., Colditz, G. A., Hunter, D. J., Michaud, D. S., Deroo, B., Rosner, B., Speizer, F. E., & Pollak, M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)10384-1 · Cited by 1,823
Renehan, A. G., Zwahlen, M., Minder, C., O'Dwyer, S. T., Shalet, S. M., & Egger, M. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16044-3 · Cited by 1,697
Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression
Yu, H. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1472 · Cited by 1,424
VEGF-D promotes the metastatic spread of tumor cells via the lymphatics
Stacker, S. A., Caesar, C., Baldwin, M. E., Thornton, G. E., Williams, R. A., Prevo, R., Jackson, D. G., Nishikawa, S.-I., Kubo, H., & Achen, M. G. (2001) · Nature Medicine · doi:10.1038/84635 · Cited by 1,246
Cyclin D1 Expression Is Regulated Positively by the p42/p44 and Negatively by the p38/HOG Pathway
Lavoie, J. N., L'Allemain, G., Brunet, A., Müller, R., & Pouysségur, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.34.20608 · Cited by 1,211
Ma, J., Pollak, M. N., Giovannucci, E., Chan, J. M., Tao, Y., Hennekens, C. H., & Stampfer, M. J. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.7.620 · Cited by 1,119
Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis
Mandriota, S. J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.4.672 · Cited by 978
Glycosylation defining cancer malignancy: New wine in an old bottle
Hakomori, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172380699 · Cited by 960
Frasca, F., Pandini, G., Scalia, P., Sciacca, L., Mineo, R., Costantino, A., Goldfine, I. D., Belfiore, A., & Vigneri, R. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3278 · Cited by 902
Induction of the growth inhibitor IGF-binding protein 3 by p53
Buckbinder, L., Talbott, R., Velasco-Miguel, S., Takenaka, I., Faha, B., Seizinger, B. R., & Kley, N. (1995) · Nature · doi:10.1038/377646a0 · Cited by 869
Fukuda, R., Hirota, K., Fan, F., Jung, Y. D., Ellis, L. M., & Semenza, G. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203781200 · Cited by 821
Loss of IGF2 Imprinting: A Potential Marker of Colorectal Cancer Risk
Cui, H., Cruz-Correa, M., Giardiello, F. M., Hutcheon, D. F., Kafonek, D. R., Brandenburg, S., Wu, Y., He, X., Powe, N. R., & Feinberg, A. P. (2003) · Science · doi:10.1126/science.1080902 · Cited by 735
Massagué, J., & Czech, M. P. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34631-3 · Cited by 711
Growth factors in development, transformation, and tumorigenesis
Cross, M., & Dexter, T. M. (1991) · Cell · doi:10.1016/0092-8674(91)90638-f · Cited by 694
Requirement of p27 Kip1 for Restriction Point Control of the Fibroblast Cell Cycle
Coats, S., Flanagan, W. M., Nourse, J., & Roberts, J. M. (1996) · Science · doi:10.1126/science.272.5263.877 · Cited by 679
Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2.
Feldser, D. M., Agani, F. H., Iyer, N. V., Pak, B. J., Ferreira, G., & Semenza, G. L. (1999) · PubMed · Cited by 631
Mitsiades, C. S., Mitsiades, N. S., McMullan, C. J., Poulaki, V., Shringarpure, R., Akiyama, M., Hideshima, T., Chauhan, D., Joseph, M., Libermann, T. A., et al. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00050-9 · Cited by 614
Frangioni, J. V., Beahm, P. H., Shifrin, V., Jost, C. A., & Neel, B. G. (1992) · Cell · doi:10.1016/0092-8674(92)90190-n · Cited by 595
Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha /ARNT
Zelzer, E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5085 · Cited by 575
Distinct and Overlapping Functions of Insulin and IGF-I Receptors
Nakae, J., Kido, Y., & Accili, D. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.6.0452 · Cited by 554
Plasma Levels of Insulin-Like Growth Factor-I and Lung Cancer Risk: a Case-Control Analysis
Yu, H., Spitz, M. R., Mistry, J., Gu, J., Hong, W. K., & Wu, X. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.2.151 · Cited by 554
Insulin-like growth factors and cancer
Fürstenberger, G., & Senn, H.-J. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00731-3 · Cited by 536
Repression of the Insulin-Like Growth Factor II Gene by the Wilms Tumor Suppressor WT1
Drummond, L. A., Madden, S. L., Rohwer-Nutter, P., Bell, G. I., Sukhatme, V. P., & Rauscher, F. J. (1992) · Science · doi:10.1126/science.1323141 · Cited by 525
Muise-Helmericks, R. C., Grimes, H. L., Bellacosa, A., Malstrom, S. E., Tsichlis, P. N., & Rosen, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29864 · Cited by 511
Vascular Growth Factors and Lymphangiogenesis
Jussila, L., & Alitalo, K. (2002) · Physiological Reviews · doi:10.1152/physrev.00005.2002 · Cited by 443
Koeneman, K. S., Yeung, F., & Chung, L. W. K. (1999) · The Prostate · doi:10.1002/(sici)1097-0045(19990601)39:4<246::aid-pros5>3.0.co;2-u · Cited by 440
The IGF-I receptor in cell growth, transformation and apoptosis
Baserga, R., Hongo, A., Rubini, M., Prisco, M., & Valentinis, B. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00007-3 · Cited by 439
Dunn, S. E., Kari, F. W., French, J. E., Leininger, J. R., Travlos, G. S., Wilson, R., & Barrett, J. C. (1997) · PubMed · Cited by 438
Goldstein, B. J., Bittner-Kowalczyk, A., White, M. F., & Harbeck, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.4283 · Cited by 419
Stattin, P. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.23.1910 · Cited by 404
Giovannucci, E. L., Pollak, M., Platz, E. A., Willett, W. C., Stampfer, M. J., Majeed, N., Colditz, G. A., Speizer, F. E., & Hankinson, S. E. (2000) · PubMed · Cited by 401
Yee, D., Paik, S., Lebovic, G. S., Marcus, R. R., Favoni, R. E., Cullen, K. J., Lippman, M. E., & Rosen, N. (1989) · Molecular Endocrinology · doi:10.1210/mend-3-3-509 · Cited by 399
Motyka, B., Korbutt, G., Pinkoski, M. J., Heibein, J. A., Caputo, A., Hobman, M., Barry, M., Shostak, I., Sawchuk, T., Holmes, C. F. B., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00140-9 · Cited by 398
Role of insulin-like growth factor binding proteins in controlling IGF actions
Clemmons, D. R. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00024-0 · Cited by 392
Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis.
Wu, Y., Yakar, S., Zhao, L., Hennighausen, L. G., & LeRoith, D. (2002) · PubMed · Cited by 380
Self-citationHellawell, G. O., Turner, G. D. H., Davies, D. R., Poulsom, R., BREWSTER, S. F., & Macaulay, V. M. (2002) · PubMed · Cited by 372
The Role of the IGF System in Cancer: From Basic to Clinical Studies and Clinical Applications
Moschos, S. J., & Mantzoros, C. S. (2002) · Oncology · doi:10.1159/000066230 · Cited by 371
Werner, H., Karnieli, E., Rauscher, F. J., & LeRoith, D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8318 · Cited by 370
Self-citationCohen, B. D., Baker, D. A., Soderstrom, C., Tkalcevic, G., Rossi, A. M., Miller, P. E., Tengowski, M. W., Wang, F., Gualberto, A., Beebe, J. S., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1070 · Cited by 365
Association of insulin receptor substrate-1 with integrins
Vuori, K., & Ruoslahti, E. (1994) · Science · doi:10.1126/science.7527156 · Cited by 360
Fowlkes, J. L., Enghild, J. J., Suzuki, K., & Nagase, H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47310-3 · Cited by 347
Serum insulin-like growth factor-I and breast cancer
Toniolo, P., Bruning, P. F., Akhmedkhanov, A., Bonfrer, J. M. G., Koenig, K. L., Lukanova, A., Shore, R. E., & Zeleniuch-Jacquotte, A. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20001201)88:5<828::aid-ijc22>3.0.co;2-8 · Cited by 341
Trojan, J., Johnson, T. R., Rudin, S. D., Ilan, J., Tykocinski, M. L., & Ilan, J. (1993) · Science · doi:10.1126/science.8418502 · Cited by 329
Regulation of Membrane Type-1 Matrix Metalloproteinase Activation by Proprotein Convertases
Yana, I., & Weiss, S. J. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.7.2387 · Cited by 322
Loss of Imprinting of Igf2 Alters Intestinal Maturation and Tumorigenesis in Mice
Sakatani, T., Kaneda, A., Iacobuzio-Donahue, C. A., Carter, M. G., de Boom Witzel, S., Okano, H., Ko, M. S. H., Ohlsson, R., Longo, D. L., & Feinberg, A. P. (2005) · Science · doi:10.1126/science.1108080 · Cited by 321
Rubin, R., & Baserga, R. (1995) · PubMed · Cited by 311
Bergmann, U., Funatomi, H., Yokoyama, M., Beger, H. G., & Korc, M. (1995) · PubMed · Cited by 304
Scotlandi, K., Manara, M. C., Nicoletti, G., Lollini, P.-L., Lukas, S., Benini, S., Croci, S., Perdichizzi, S., Zambelli, D., Serra, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3192 · Cited by 299
Sciacca, L., Costantino, A., Pandini, G., Mineo, R., Frasca, F., Scalia, P., Sbraccia, P., Goldfine, I. D., Vigneri, R., & Belfiore, A. (1999) · Oncogene · doi:10.1038/sj.onc.1202600 · Cited by 288
Gicquel, C., BERTAGNA, X. Y., Gaston, V., Coste, J., Louvel, A., Baudin, É., Bertherat, J. Y., Chapuis, Y., Duclos, J. M., Schlumberger, M. J., et al. (2001) · PubMed · Cited by 285
DiGiovanni, J., Kiguchi, K., Frijhoff, A., Wilker, E., Bol, D. K., Beltrán, L., Moats, S., Ramirez, A., Jorcano, J., & Conti, C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3455 · Cited by 281
Palmqvist, R., Hallmans, G., Rinaldi, S., Biessy, C., Stenling, R., Riboli, E., & Kaaks, R. (2002) · Gut · doi:10.1136/gut.50.5.642 · Cited by 280
Charalambous, M., Smith, F. M., Bennett, W. R., Crew, T. E., Mackenzie, F., & Ward, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1532175100 · Cited by 279
Lopez, T., & Hanahan, D. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00055-7 · Cited by 268
Myers, M. G., Grammer, T. C., Wang, L. M., Sun, X. J., Pierce, J. H., Blenis, J., & White, M. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61974-5 · Cited by 261
Butler, A. A., Yakar, S., Gewolb, I. H., Karas, M., Okubo, Y., & LeRoith, D. (1998) · Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology · doi:10.1016/s0305-0491(98)10106-2 · Cited by 255
Self-citationPandini, G., Vigneri, R., Costantino, A., Frasca, F., Ippolito, A. M., Fujita‐Yamaguchi, Y., Siddle, K., Goldfine, I. D., & Belfiore, A. (1999) · PubMed · Cited by 255
Crystal structure of the first three domains of the type-1 insulin-like growth factor receptor
Garrett, T. P. J., McKern, N. M., Lou, M., Frenkel, M. J., Bentley, J. D., Lovrecz, G. O., Elleman, T. C., Cosgrove, L. J., & Ward, C. W. (1998) · Nature · doi:10.1038/28668 · Cited by 254
Vecchione, A., Marchese, A., Henry, P., Rotin, D., & Morrione, A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.9.3363-3372.2003 · Cited by 251
Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo
Björndahl, M., Cao, R., Nissen, L. J., Clasper, S., Johnson, L. A., Xue, Y., Zhou, Z., Jackson, D., Jon Hansen, A., & Cao, Y. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507865102 · Cited by 249
Argetsinger, L. S., Hsu, G. W., Myers, M. G., Billestrup, N., White, M. F., & Carter-Su, C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.24.14685 · Cited by 246
Mechanism of STAT3 Activation by Insulin-like Growth Factor I Receptor
Zong, C. S., Chan, J., Levy, D. E., Horvath, C., Sadowski, H. B., & Wang, L.-H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000089200 · Cited by 240
Expression of insulin-like growth factor-1 receptor in human colorectal cancer
Hakam, A., Yeatman, T. J., Lu, L., Mora, L., Marcet, G., Nicosia, S. V., Karl, R. C., & Coppola, D. (1999) · Human Pathology · doi:10.1016/s0046-8177(99)90027-8 · Cited by 239
Burfeind, P., Chernicky, C. L., Rininsland, F., Ilan, J., & Ilan, J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7263 · Cited by 238
Bohula, E. A., Salisbury, A. J., Sohail, M., Playford, M. P., Riedemann, J., Southern, E. M., & Macaulay, V. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300714200 · Cited by 237
Pietrzkowski, Z. J., Mulholland, G., Gomella, L. G., Jameson, B. A., Wernicke, D., & Baserga, R. (1993) · PubMed · Cited by 236
Resnicoff, M., Coppola, D., Sell, C., Rubin, R., Ferrone, S., & Baserga, R. (1994) · PubMed · Cited by 231
Proprotein convertases: “Master switches” in the regulation of tumor growth and progression
Bassi, D. E., Fu, J., Lopez de Cicco, R., & Klein-Szanto, A. J. P. (2005) · Molecular Carcinogenesis · doi:10.1002/mc.20134 · Cited by 229
Kondo, T., Vicent, D., Suzuma, K., Yanagisawa, M., King, G. L., Holzenberger, M., & Kahn, C. R. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17455 · Cited by 228
A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma.
Bosher, J. M., Totty, N. F., Hsuan, J. J., Williams, T., & Hurst, H. C. (1996) · PubMed · Cited by 225
Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans
Conover, C. A. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.74.6.1355 · Cited by 223
Mdm2-dependent ubiquitination and degradation of the insulin-like growth factor 1 receptor
Girnita, L., Girnita, A., & Larsson, O. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1431613100 · Cited by 223
Kaplan, P. J., Mohan, S., Cohen, P., Foster, B. A., & Greenberg, N. M. (1999) · PubMed · Cited by 215
Critical Steps in Hematogenous Metastasis
Chambers, A. F., Naumov, G. N., Varghese, H. J., Nadkarni, K. V., MacDonald, I. C., & Groom, A. C. (2001) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(18)30063-2 · Cited by 210
Yamada, T., De Souza, A. T., Finkelstein, S., & Jirtle, R. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10351 · Cited by 208
M6P/IGF2 receptor: a candidate breast tumor suppressor gene.
Hankins, G. R., Souza, A. T. D., Bentley, R. C., Patel, M. R., Marks, J. R., Iglehart, J. D., & Jirtle, R. L. (1996) · PubMed · Cited by 204
Hermanto, U., Zong, C. S., Li, W., & Wang, L.-H. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.7.2345-2365.2002 · Cited by 204
Wu, Y., Cui, K. Y., Miyoshi, K., Hennighausen, L. G., Green, J. E., Setser, J., LeRoith, D., & Yakar, S. (2003) · PubMed · Cited by 201
Self-citationCariani, E., Lasserre, C., Seurin, D., Hamelin, B., Kemeny, F., Franco, D., Czech, M., Ullrich, A., & Bréchot, C. (1988) · PubMed · Cited by 193
Critical steps in hematogenous metastasis: an overview.
Chambers, A. F., Naumov, G. N., Varghese, H. J., Nadkarni, K. V., MacDonald, I. C., & Groom, A. C. (2001) · PubMed · Cited by 191
Gooch, J. L., Van Den Berg, C. L., & Yee, D. (1999) · Breast Cancer Research and Treatment · doi:10.1023/a:1006208721167 · Cited by 191
Sachdev, D., Li, S. L., Hartell, J. S., Fujita‐Yamaguchi, Y., Miller, J. S., & Yee, D. (2003) · PubMed · Cited by 190
Kim, K., Bae, S. K., Lee, O., Bae, M.-H., Lee, M. J., & Park, B. C. (1998) · PubMed · Cited by 190
Levels of Insulin-like Growth Factors I and II in Human Cord Blood*
BENNETT, A., WILSON, D. M., LIU, F., NAGASHIMA, R., ROSENFELD, R. G., & HINTZ, R. L. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-3-609 · Cited by 188
Mañes, S., Llorente, M., Lacalle, R. A., Gómez-Moutón, C., Kremer, L., Mira, E., & Martı́nez-A, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.11.6935 · Cited by 188
Knowlden, J. M., Hutcheson, I. R., Barrow, D., Gee, J. M. W., & Nicholson, R. I. (2005) · Endocrinology · doi:10.1210/en.2005-0247 · Cited by 188
Coordinated action of protein tyrosine phosphatases in insulin signal transduction
Cheng, A., Dubé, N., Gu, F., & Tremblay, M. L. (2002) · European Journal of Biochemistry · doi:10.1046/j.0014-2956.2002.02756.x · Cited by 187
Lin, F.-T., Daaka, Y., & Lefkowitz, R. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.48.31640 · Cited by 182
All‐Ericsson, C., Girnita, L., Seregard, S., Bartolazzi, A., Jager, M. J., & Larsson, O. (2002) · PubMed · Cited by 178
Tennant, M. K. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.10.3774 · Cited by 171
Wang, Y., Hailey, J., Williams, D., Wang, Y., Lipari, P., Malkowski, M., Wang, X., Xie, L., Li, G., Saha, D., et al. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0048 · Cited by 171
Khatib, A.-M., Siegfried, G., Prat, A., Luis, J., Chrétien, M., Metrakos, P., & Seidah, N. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101725200 · Cited by 170
Giorgetti, S., Ballotti, R., Kowalski-Chauvel, A., Tartare, S., & Van Obberghen, E. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53183-5 · Cited by 167
Rosenthal, S. M., & Cheng, Z. Q. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.22.10307 · Cited by 166
Myers, M. G., Mendez, R., Shi, P., Pierce, J. H., Rhoads, R., & White, M. F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26908 · Cited by 164
Thrailkill, K. M., Quarles, L. D., Nagase, H., Suzuki, K., SERRA, D. M., & Fowlkes, J. L. (1995) · Endocrinology · doi:10.1210/en.136.8.3527 · Cited by 163
Girnita, L., Shenoy, S. K., Sehat, B., Vasilcanu, R., Girnita, A., Lefkowitz, R. J., & Larsson, O. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501129200 · Cited by 162
Sciacca, L., Mineo, R., Pandini, G., Murabito, A., Vigneri, R., & Belfiore, A. (2002) · Oncogene · doi:10.1038/sj.onc.1206058 · Cited by 162
Insulin-like Growth Factors in Health and Disease
LeRoith, D., Clemmons, D., Nissley, P., & Rechler, M. M. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-10-854 · Cited by 160
Self-citationSatyamoorthy, K., Li, G., Vaidya, B., Patel, D., & Herlyn, M. (2001) · PubMed · Cited by 159
Criswell, T. L., Beman, M., Araki, S., Leskov, K., Cataldo, E., Mayo, L. D., & Boothman, D. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412569200 · Cited by 157
Reduced growth of human breast cancer xenografts in hosts homozygous for the lit mutation.
Yang, X., Beamer, W. G., Huynh, H. T., & Pollak, M. (1996) · PubMed · Cited by 157
Dupont, J., Karas, M., & LeRoith, D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006741200 · Cited by 155
Self-citationIncreased Tumor Growth in Mice with Diet-Induced Obesity: Impact of Ovarian Hormones
Yakar, S., Núñez, N. P., Pennisi, P. A., Brodt, P., Sun, H., Fallavollita, L., Zhao, H., Scavo, L. M., Novosyadlyy, R., Kurshan, N., et al. (2006) · Endocrinology · doi:10.1210/en.2006-0311 · Cited by 155
Self-citationChi, M. M.-Y., Schlein, A. L., & Moley, K. H. (2000) · Endocrinology · doi:10.1210/endo.141.12.7816 · Cited by 154
Miyamoto, S., Yano, K., Sugimoto, S., Ishii, G., Hasebe, T., Endoh, Y., Kodama, K., Goya, M., Chiba, T., & Ochiai, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1916 · Cited by 154
Kalli, K. R., Falowo, O. I., Bale, L. K., Zschunke, M. A., Roche, P. C., & Conover, C. A. (2002) · Endocrinology · doi:10.1210/en.2001-211408 · Cited by 154
Wrobel, G., Roerig, P., Kokocinski, F., Neben, K., Hahn, M., Reifenberger, G., & Lichter, P. (2004) · International Journal of Cancer · doi:10.1002/ijc.20733 · Cited by 152
Dual Regulation of MMP-2 Expression by the Type 1 Insulin-like Growth Factor Receptor
Zhang, D., Bar‐Eli, M., Meloche, S., & Brodt, P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313145200 · Cited by 152
Self-citationKawesha, A., Ghaneh, P., Andrén‐Sandberg, Å., Ögraed, D., Skar, R., Dawiskiba, S., Evans, J. D., Campbell, F., Lemoine, N. R., & Neoptolemos, J. P. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20001120)89:6<506::aid-ijc7>3.0.co;2-f · Cited by 152
Shariat, S. F., Lamb, D. J., Kattan, M. W., Nguyen, C. V., Kim, J., Beck, J., Wheeler, T. M., & Slawin, K. M. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.3.833 · Cited by 151
The Insulin Receptor Isoform Exon 11- (IR-A) in Cancer and Other Diseases: A Review
Denley, A., Wallace, J. C., Cosgrove, L. J., & Forbes, B. E. (2003) · Hormone and Metabolic Research · doi:10.1055/s-2004-814157 · Cited by 150
Expression of the insulin-like growth factors and their receptors in adenocarcinoma of the colon
Freier, S., Weiss, O., Eran, M., Flyvbjerg, A., Dahan, R., Nephesh, I., Safra, T., Shiloni, E., & Raz, I. (1999) · Gut · doi:10.1136/gut.44.5.704 · Cited by 150
Kiely, P. A., Sant, A., & O’Connor, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201758200 · Cited by 150
Turner, B. C., Zhang, J., Gumbs, A. A., Maher, M. G., Kaplan, L., Carter, D., Glazer, P. M., Hurst, H. C., Haffty, B. G., & Williams, T. (1998) · PubMed · Cited by 150
Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer.
Lee, H., Chun, K., Liu, B., Wiehle, S., Cristiano, R. J., Hong, W. K., Cohen, P., & Kurie, J. M. (2002) · PubMed · Cited by 150
Zhang, D., & Brodt, P. (2003) · Oncogene · doi:10.1038/sj.onc.1206197 · Cited by 149
Self-citationWebster, N. J. G., Resnik, J. L., Reichart, D. B., Strauss, B. E., Haas, M., & Seely, B. L. (1996) · PubMed · Cited by 149
Fizazi, K. S., Yang, J., Peleg, S., Sikes, C. R., Kreimann, E. L., Daliani, D., Olivé, M., Raymond, K. A., Janus, T. J., Logothetis, C. J., et al. (2003) · PubMed · Cited by 147
Huo, H., Guo, X., Hong, S., Jiang, M., Liu, X., & Liao, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211785200 · Cited by 145
Zhao, H., Dupont, J., Yakar, S., Karas, M., & LeRoith, D. (2004) · Oncogene · doi:10.1038/sj.onc.1207162 · Cited by 142
Self-citationZhao, H., Grossman, H. B., Spitz, M. R., Lerner, S. P., ZHANG, K., & Wu, X. (2003) · The Journal of Urology · doi:10.1016/s0022-5347(05)63999-7 · Cited by 138
Carlberg, M., Dricu, A., Blegen, H., Wang, M., Hjertman, M., Zickert, P., Höög, A., & Larsson, O. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.29.17453 · Cited by 137
Bauer, T. W., Liu, W., Fan, F., Camp, E. R., Yang, A. D., Somcio, R., Bucana, C. D., Callahan, J. A., Parry, G. C., Evans, D. B., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0946 · Cited by 137
Blocking the insulin-like growth factor-I receptor as a strategy for targeting cancer
Hofmann, F., & Garcı́a-Echeverrı́a, C. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03512-9 · Cited by 136
Chang, Y. S., Wang, L., Liu, D., Mao, L., Hong, W. K., Khuri, F. R., & Lee, H. (2002) · PubMed · Cited by 136
Nakamura, M., Miyamoto, S., Maeda, H., Ishii, G., Hasebe, T., Chiba, T., Asaka, M., & Ochiai, A. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.06.010 · Cited by 135
Jackson, J. G., Zhang, X., Yoneda, T., & Yee, D. (2001) · Oncogene · doi:10.1038/sj.onc.1204920 · Cited by 129
Probst-Hensch, N. M., Yuan, J.-M., Stanczyk, F. Z., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2172 · Cited by 127
McCarthy, T. L., Casinghino, S. R., & CANALIS, E. M. (1994) · Journal of Cellular Physiology · doi:10.1002/jcp.1041600119 · Cited by 125
Reduced mammary gland carcinogenesis in transgenic mice expressing a growth hormone antagonist
Pollak, M., Blouin, M.-J., Zhang, J.-C., & Kopchick, J. J. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1895 · Cited by 123
Wang, Y. Z., & Wong, Y. C. (1998) · The Prostate · Cited by 123
Sandberg, A.-C., Engberg, C., Lake, M., von Holst, H., & Sara, V. R. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90022-5 · Cited by 123
Hartmann, W., Koch, A., Brune, H., Waha, A., Schüller, U., Dani, I., Denkhaus, D., Langmann, W., Bode, U., Wiestler, O. D., et al. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62335-8 · Cited by 122
Chang, Q., Li, Y., White, M. F., Fletcher, J. A., & Xiao, S. (2002) · PubMed · Cited by 121
Christofori, G., Naik, P., & Hanahan, D. (1995) · Nature Genetics · doi:10.1038/ng0695-196 · Cited by 121
Kuhn, C., Hurwitz, S. A., Kumar, M. G., Cotton, J. P., & Spandau, D. F. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990129)80:3<431::aid-ijc16>3.0.co;2-5 · Cited by 120
Association of Insulin-like Growth Factor 1 Receptor with EHD1 and SNAP29
Rotem-Yehudar, R., Galperin, E., & Horowitz, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009913200 · Cited by 120
Post-translational Processing of the Insulin-like Growth Factor-2 Precursor
Duguay, S. J., Jin, Y., Stein, J. M., Duguay, A. N., Gardner, P., & Steiner, D. F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18443 · Cited by 118
Petley, T., Graff, K., Jiang, W., Yang, H., & Florini, J. R. (1999) · Hormone and Metabolic Research · doi:10.1055/s-2007-978701 · Cited by 117
Ogawa, O., Becroft, D. M. O., Morison, I. M., Eccles, M. R., Skeen, J., Mauger, D. C., & Reeve, A. E. (1993) · Nature Genetics · doi:10.1038/ng1293-408 · Cited by 116
Buckley, D. A., Cheng, A., Kiely, P. A., Tremblay, M. L., & O’Connor, R. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.7.1998-2010.2002 · Cited by 115
Héron‐Milhavet, L., & LeRoith, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111142200 · Cited by 114
Self-citationAllen, N. E., Roddam, A. W., Allen, D., Fentiman, I., Silva, I. D. S., Peto, J., Holly, J. M. P., & Key, T. J. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602471 · Cited by 114
Gual, P., Baron, V. T., Lequoy, V., & OBBERGHEN, E. V. (1998) · Endocrinology · doi:10.1210/endo.139.3.5829 · Cited by 112
Werner, H., Shen‐Orr, Z., Rauscher, F. J., Morris, J. F., Roberts, C. T., & LeRoith, D. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.7.3516 · Cited by 111
Self-citationShimizu, C., Hasegawa, T., Tani, Y., et al. (2004) · Human Pathology · doi:10.1016/j.humpath.2004.09.005 · Cited by 109
Tyrphostin AG 1024 modulates radiosensitivity in human breast cancer cells
Wen, B., Deutsch, É., Marangoni, E., Frascona, V., Maggiorella, L., Abdulkarim, B., Chavaudra, N., & Bourhis, J. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2171 · Cited by 108
Baron, V. T., Calleja, V., Ferrari, P., Alengrin, F., & OBBERGHEN, E. V. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.12.7162 · Cited by 108
Railo, M. J., von Smitten, K., & Pekonen, F. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90247-x · Cited by 103
Expression of IGF-I and IGF-II mRNA in breast tissue
Paik, S. (1992) · Breast Cancer Research and Treatment · doi:10.1007/bf01833331 · Cited by 103
Grey, A. B., Chen, Q., Xu, X., Callon, K. E., & Cornish, J. (2003) · Endocrinology · doi:10.1210/en.2003-0350 · Cited by 102
Insulin-like growth factor I receptor activity in human medulloblastomas.
Valle, L. D., Enam, S., Lassak, A., Wang, J. Y., Croul, S. E., Khalili, K., & Reiss, K. (2002) · PubMed · Cited by 102
Zhang, L., Kashanchi, F., Zhan, Q., Zhan, S., Brady, J. N., Fornace, A. J., Seth, P. K., & Helman, L. J. (1996) · PubMed · Cited by 101
Martin, D. C., Fowlkes, J. L., Babic, B., & Khokha, R. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.4.881 · Cited by 101
Liao, Y., Abel, U. R., Grobholz, R., et al. (2005) · Human Pathology · doi:10.1016/j.humpath.2005.07.023 · Cited by 100
Casamassima, A., & Rozengurt, E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.26149 · Cited by 100
Mira, E., Mañes, S., Lacalle, R. A., Márquez, G., & Martínez‐A, C. (1999) · Endocrinology · doi:10.1210/endo.140.4.6623 · Cited by 100
Lee, O.-H., Bae, S. K., Bae, M., Lee, Y. M., Moon, E., J, H., Kwon, Y., & Kim, K. W. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.0931 · Cited by 99
Egr-1 mediates transcriptional activation of IGF-II gene in response to hypoxia.
Bae, S. K., Bae, M.-H., Ahn, M. Y., Son, M. J., Lee, Y. M., Bae, M., Lee, O., Park, B. C., & Kim, K. (1999) · PubMed · Cited by 99
Chang, Y. S., Kong, G., Sun, S., Liu, D., El‐Naggar, A. K., Khuri, F. R., Hong, W. K., Lee, H., & Gong, K. (2002) · PubMed · Cited by 99
Hemers, E., Duval, C., McCaig, C., Handley, M. T., Dockray, G. J., & Varró, A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0157 · Cited by 97
Duguay, S. J., Milewski, W. M., Young, B. D., Nakayama, K., & Steiner, D. F. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.10.6663 · Cited by 97
Cooperative interaction between mutant p53 and des(1-3)IGF-I accelerates mammary tumorigenesis
Hadsell, D. L., Murphy, K. L., Bonnette, S. G., Reece, N., Laucirica, R., & Rosen, J. M. (2000) · Oncogene · doi:10.1038/sj.onc.1203386 · Cited by 97
Maile, L. A., & Clemmons, D. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109258200 · Cited by 95
Lee, Y. I., Lee, S., Das, G. C., Park, U. S., Park, S. M., & Lee, Y. I. (2000) · Oncogene · doi:10.1038/sj.onc.1203694 · Cited by 94
Overexpression of Insulin Receptor Substrate-2 in Human and Murine Hepatocellular Carcinoma
Boissan, M., Beurel, E., Wendum, D., Rey, C., Lécluse, Y., Housset, C., Lacombe, M., & Desbois‐Mouthon, C. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62058-5 · Cited by 93
Sayer, R. A., Lancaster, J. M., Pittman, J., et al. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.10.012 · Cited by 93
Zong, C. S., Zeng, L., Jiang, Y., Sadowski, H. B., & Wang, L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.43.28065 · Cited by 92
Relevance of biologic markers in colorectal carcinoma
Barozzi, C., Ravaioli, M., D’Errico, A., et al. (2002) · Cancer · doi:10.1002/cncr.10278 · Cited by 92
Insulin-like growth factor-I induces cyclin-D1 expression in MG63 human osteosarcoma cells in vitro
Furlanetto, R. W., Harwell, S. E., & Frick, K. K. (1994) · Molecular Endocrinology · doi:10.1210/mend.8.4.8052269 · Cited by 89
Enhanced expression of the insulin receptor substrate-2 docking protein in human pancreatic cancer.
Kornmann, M., Maruyama, H., Bergmann, U., Tangvoranuntakul, P., Beger, H. G., White, M. F., & Korc, M. (1998) · PubMed · Cited by 89
Cardillo, M. R., Monti, S., Silverio, F. D., Gentile, V., Sciarra, F., & Toscano, V. (2003) · PubMed · Cited by 89
Hursting, S. D., Switzer, B. R., French, J. E., & Kari, F. W. (1993) · PubMed · Cited by 88
Clarke, K., Smith, K. J., Gullick, W., & Harris, A. L. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1805 · Cited by 88
LeBedis, C. A., Chen, K., Fallavollita, L., Boutros, T., & Brodt, P. (2002) · International Journal of Cancer · doi:10.1002/ijc.10481 · Cited by 87
Self-citationKrassas, G. E., Pontikides, N., Kaltsas, T., Dumas, A., Frystyk, J., Chen, J. W., & Flyvbjerg, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021349 · Cited by 87
Insulin-like growth factor-I signaling in human neuroblastoma cells
Kim, B., van Golen, C. M., & Feldman, E. L. (2004) · Oncogene · doi:10.1038/sj.onc.1206924 · Cited by 87
Transcripts of the insulin-like growth factors I and II in human hepatoma.
Su, T., Liu, W. Y., Han, S. H., et al. (1989) · PubMed · Cited by 86
Zhang, D., Samani, A. A., & Brodt, P. (2003) · Hormone and Metabolic Research · doi:10.1055/s-2004-814143 · Cited by 86
Self-citationTang, Y., Zhang, D., Fallavollita, L., et al. (2003) · PubMed · Cited by 84
The Insulin-like Growth Factor Axis in Cell Cycle Progression
Dupont, J., Pierre, A.-S., Froment, P., & Moreau, C. (2003) · Hormone and Metabolic Research · doi:10.1055/s-2004-814162 · Cited by 82
O’Gorman, D. B., Weiss, J., Hettiaratchi, A., Firth, S. M., & Scott, C. D. (2002) · Endocrinology · doi:10.1210/en.2002-220548 · Cited by 82
Tode, B., Serio, M., Rotella, C. M., Galli, G., Franceschelli, F., Tanini, A., & Toccafondi, R. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-69-3-639 · Cited by 81
Clemmons, D. R., & Maile, L. A. (2003) · Endocrinology · doi:10.1210/en.2002-221102 · Cited by 79
Increased Expression of Insulin Receptor Substrate-1 in Human Pancreatic Cancer
Bergmann, U., Funatomi, H., Kornmann, M., Beger, H. G., & Korc, M. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0500 · Cited by 79
A Novel Fetal Insulin-Like Growth Factor (IGF) I Receptor
Alexandrides, T. K., & Smith, R. J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)51576-3 · Cited by 76
Surgical management of adrenal metastases from lung cancer
Beitler, A. L., Urschel, J. D., Velagapudi, S., & Takita, H. (1998) · Journal of Surgical Oncology · doi:10.1002/(sici)1096-9098(199809)69:1<21::aid-jso5>3.0.co;2-m · Cited by 75
Jiang, Y., Wang, L., Gong, W., Wei, D., Le, X., Yao, J. C., Ajani, J. A., Abbruzzese, J. L., Huang, S., & Xie, K. (2005) · Clinical & Experimental Metastasis · doi:10.1007/s10585-005-1198-2 · Cited by 74
Growth hormone / insulin-like growth factor-1 axis during puberty.
Christoforidis, A., Maniadaki, I., & Stanhope, R. G. (2005) · PubMed · Cited by 71
Cited by
Insulin and insulin-like growth factor signalling in neoplasia
Pollak, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2536 · Cited by 2,059
Angiogenic signaling pathways and anti-angiogenic therapy for cancer
Liu, Z.-L., Chen, H.-H., Zheng, L.-L., Sun, L.-P., & Shi, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01460-1 · Cited by 1,300
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
Currie, C. J., Poole, C. D., & Gale, E. A. M. (2009) · Diabetologia · doi:10.1007/s00125-009-1440-6 · Cited by 1,124
Belfiore, A., Frasca, F., Pandini, G., Sciacca, L., & Vigneri, R. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0047 · Cited by 1,033
Else, T., Kim, A. C., Sabolch, A., Raymond, V. M., Kandathil, A., Caoili, E. M., Jolly, S., Miller, B. S., Giordano, T. J., & Hammer, G. D. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1029 · Cited by 892
Metadata
- Authors
- Samani, A. A., Yakar, S., LeRoith, D., & Brodt, P.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2007-02-01
- Volume
- 28
- Issue
- 1
- Pages
- 20-47
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2051839343
- Cited by
- 1,005
- References
- 260
- FWCI
- 54.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.